83 related articles for article (PubMed ID: 15312677)
1. MHC class I manipulation on cell surfaces by gene transfer of anti-MHC class I intrabodies--a tool for decreased immunogenicity of allogeneic tissue and cell transplants.
Busch A; Marasco WA; Doebis C; Volk HD; Seifert M
Methods; 2004 Oct; 34(2):240-9. PubMed ID: 15312677
[TBL] [Abstract][Full Text] [Related]
2. Decline of surface MHC I by adenoviral gene transfer of anti-MHC I intrabodies in human endothelial cells-new perspectives for the generation of universal donor cells for tissue transplantation.
Beyer F; Doebis C; Busch A; Ritter T; Mhashilkar A; Marasco WM; Laube H; Volk HD; Seifert M
J Gene Med; 2004 Jun; 6(6):616-23. PubMed ID: 15170732
[TBL] [Abstract][Full Text] [Related]
3. Intrabody-mediated phenotypic knockout of major histocompatibility complex class I expression in human and monkey cell lines and in primary human keratinocytes.
Mhashilkar AM; Doebis C; Seifert M; Busch A; Zani C; Soo Hoo J; Nagy M; Ritter T; Volk HD; Marasco WA
Gene Ther; 2002 Mar; 9(5):307-19. PubMed ID: 11938450
[TBL] [Abstract][Full Text] [Related]
4. Immune responsiveness against allogeneic platelet transfusions is determined by the recipient's major histocompatibility complex class II phenotype.
Sayeh E; Aslam R; Speck ER; Le-Tien H; Lazarus AH; Freedman J; Semple JW
Transfusion; 2004 Nov; 44(11):1572-8. PubMed ID: 15504162
[TBL] [Abstract][Full Text] [Related]
5. Modulation of graft arteriosclerosis in a rat carotid transplantation model.
Zdoroveac A; Doebis C; Laube H; Brösel S; Schmitt-Knosalla I; Volk HD; Seifert M
J Surg Res; 2008 Mar; 145(1):161-9. PubMed ID: 18164034
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies.
Li B; Simmons A; Du T; Lin C; Moskalenko M; Gonzalez-Edick M; VanRoey M; Jooss K
Clin Immunol; 2009 Nov; 133(2):184-97. PubMed ID: 19664962
[TBL] [Abstract][Full Text] [Related]
7. Absence of major histocompatibility complex class I on neural stem cells does not permit natural killer cell killing and prevents recognition by alloreactive cytotoxic T lymphocytes in vitro.
Mammolenti M; Gajavelli S; Tsoulfas P; Levy R
Stem Cells; 2004; 22(6):1101-10. PubMed ID: 15536199
[TBL] [Abstract][Full Text] [Related]
8. MHC expression in a human adult stem cell line and its down-regulation by hCMV US gene transfection.
Kim JY; Kim D; Choi I; Yang JS; Lee DS; Lee JR; Kang K; Kim S; Hwang WS; Lee JS; Ahn C
Int J Biochem Cell Biol; 2005 Jan; 37(1):69-78. PubMed ID: 15381151
[TBL] [Abstract][Full Text] [Related]
9. Immune escape phenotype of HPV16-associated tumours: MHC class I expression changes during progression and therapy.
Mikysková R; Bubeník J; Vonka V; Smahel M; Indrova M; Bieblová J; Símová J; Jandlová T
Int J Oncol; 2005 Feb; 26(2):521-7. PubMed ID: 15645139
[TBL] [Abstract][Full Text] [Related]
10. Transfection of CD40 in a human oral squamous cell carcinoma keratinocyte line upregulates immune potency and costimulatory molecules.
Villarroel Dorrego M; Whawell SA; Speight PM; Barrett AW
Br J Dermatol; 2006 Feb; 154(2):231-8. PubMed ID: 16433790
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of MHC class I expression in human neuronal stem cells using viral stealth mechanism.
Lee EM; Kim JY; Cho BR; Chung WK; Yoon BW; Kim SU; Lee BC; Hwang WS; Moon SY; Lee JS; Ahn C
Biochem Biophys Res Commun; 2005 Jan; 326(4):825-35. PubMed ID: 15607744
[TBL] [Abstract][Full Text] [Related]
12. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
Zimmerman Z; Shatry A; Deyev V; Podack E; Mammolenti M; Blazar BR; Yagita H; Levy RB
Biol Blood Marrow Transplant; 2005 Aug; 11(8):576-86. PubMed ID: 16041307
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy, IL-12 gene therapy and combined adjuvant therapy of HPV 16-associated MHC class I-proficient and -deficient tumours.
Indrová M; Bieblová J; Jandlová T; Vonka V; Pajtasz-Piasecka E; Reinis M
Int J Oncol; 2006 Jan; 28(1):253-9. PubMed ID: 16328003
[TBL] [Abstract][Full Text] [Related]
14. Selective depletion of alloreactive T lymphocytes using patient-derived nonhematopoietic stimulator cells in allograft engineering.
Nonn M; Herr W; Khan S; Todorova M; Link I; Thies J; Distler E; Kaltwasser M; Hoffmann J; Huber C; Hartwig UF
Transplantation; 2008 Nov; 86(10):1427-35. PubMed ID: 19034014
[TBL] [Abstract][Full Text] [Related]
15. Beta2-microglobulin required for cell surface expression of blastocyst MHC.
Tanaka T; Ebata T; Tajima A; Kinoshita K; Okumura K; Yagita H
Biochem Biophys Res Commun; 2005 Jun; 332(1):311-7. PubMed ID: 15896332
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of T cell homing by down-regulation of CD62L and the induction of a Th-2 response as a method to prevent acute allograft rejection in mice.
Stremmel C; Sienel W; Eggeling S; Passlick B; Slavin A
Eur J Cardiothorac Surg; 2006 Aug; 30(2):362-9. PubMed ID: 16828564
[TBL] [Abstract][Full Text] [Related]
17. Allogeneic MHC gene transfer enhances antitumor activity of allogeneic hematopoietic stem cell transplantation without exacerbating graft-versus-host disease.
Ohashi M; Kobayashi A; Hara H; Miura Y; Yoshida K; Kushida M; Ikarashi Y; Mandai M; Kitajima M; Yoshida T; Aoki K
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2208-15. PubMed ID: 16609036
[TBL] [Abstract][Full Text] [Related]
18. MHC class II-mediated antigen presentation by alloreactive rat CD4+ T cells does not induce regulatory properties.
Otto C; Heeg A; Kottenmeier S; Tiurbe GC; Thiede A; Ulrichs K
Transplant Proc; 2006 Apr; 38(3):755-6. PubMed ID: 16647463
[TBL] [Abstract][Full Text] [Related]
19. MHC class II expression by follicular keratinocytes in canine demodicosis--an immunohistochemical study.
Huisinga M; Failing K; Reinacher M
Vet Immunol Immunopathol; 2007 Aug; 118(3-4):210-20. PubMed ID: 17604845
[TBL] [Abstract][Full Text] [Related]
20. A novel tool for B-cell tolerance research: characterization of mouse alloantibody development using a simple and reliable cellular ELISA technique.
Fan X; Tyerman K; Ang A; Koo K; Parameswaran K; Tao K; Mai L; Lang H; West LJ
Transplant Proc; 2005; 37(1):29-31. PubMed ID: 15808536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
